E Vignon

580 total citations
40 papers, 461 citations indexed

About

E Vignon is a scholar working on Rheumatology, Molecular Biology and Pharmacology. According to data from OpenAlex, E Vignon has authored 40 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Rheumatology, 7 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in E Vignon's work include Osteoarthritis Treatment and Mechanisms (19 papers), Inflammatory mediators and NSAID effects (6 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). E Vignon is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (19 papers), Inflammatory mediators and NSAID effects (6 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). E Vignon collaborates with scholars based in France, United States and Belgium. E Vignon's co-authors include M. Arlot, G Vignon, Minh Nguyen, Alice Guéguen, Maxime Dougados, M Lequesne, B Mazières, Laurent Berdah, Pierre Mathieu and Thierry Conrozier and has published in prestigious journals such as Clinical Orthopaedics and Related Research, Annals of the Rheumatic Diseases and Osteoarthritis and Cartilage.

In The Last Decade

E Vignon

37 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E Vignon France	11	364	156	105	57	53	40	461
N.W. Jansen Netherlands	12	279 0.8×	196 1.3×	121 1.2×	87 1.5×	43 0.8×	19	759
Saburo Kakuta Japan	11	139 0.4×	48 0.3×	76 0.7×	107 1.9×	27 0.5×	34	413
Hiraku Kikuchi Japan	8	140 0.4×	102 0.7×	52 0.5×	60 1.1×	26 0.5×	14	321
M. Fuerst Germany	9	275 0.8×	311 2.0×	49 0.5×	80 1.4×	61 1.2×	15	588
Inyong Hwang United States	6	220 0.6×	78 0.5×	88 0.8×	83 1.5×	20 0.4×	17	414
Philippe Gillet Belgium	13	159 0.4×	497 3.2×	182 1.7×	102 1.8×	47 0.9×	21	784
Shinsuke Kihara Japan	12	148 0.4×	132 0.8×	38 0.4×	117 2.1×	27 0.5×	34	402
William Kurth Belgium	9	135 0.4×	140 0.9×	33 0.3×	57 1.0×	21 0.4×	36	322
Évelyne Verrouil France	8	232 0.6×	159 1.0×	55 0.5×	20 0.4×	29 0.5×	16	343
W. Hermann Germany	9	219 0.6×	73 0.5×	64 0.6×	89 1.6×	19 0.4×	37	443

Countries citing papers authored by E Vignon

Since Specialization

Citations

This map shows the geographic impact of E Vignon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Vignon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Vignon more than expected).

Fields of papers citing papers by E Vignon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Vignon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Vignon. The network helps show where E Vignon may publish in the future.

Co-authorship network of co-authors of E Vignon

This figure shows the co-authorship network connecting the top 25 collaborators of E Vignon. A scholar is included among the top collaborators of E Vignon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Vignon. E Vignon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Henrotin, Yves, T Conrozier, Michelle Deberg, et al.. (2011). Early decrease of serum biomarkers of type II collagen degradation (Coll2-1) and joint inflammation (Coll2-1NO2) by hyaluronic acid intra-articular injections in patients with knee osteoarthritis. Open Repository and Bibliography (University of Liège). 3 indexed citations

Conrozier, Thierry, et al.. (2009). National survey on the non-pharmacological modalities prescribed by French general practitioners in the treatment of lower limb (knee and hip) osteoarthritis. Adherence to the EULAR recommendations and factors influencing adherence.. PubMed. 26(5). 793–8. 19 indexed citations

Conrozier, Thierry, Chantal Marie Couris, Pierre Mathieu, et al.. (2008). 247 CORRELATION BETWEEN PATIENT SELF ASSESSMENT OF TREATMENT EFFICACY (PATE) AND OTHER OUTCOME VARIABLES. RESULTS OF A STANDARDIZED FOLLOW-UP IN PATIENTS TREATED WITH INTRA-ARTICULAR INJECTION OF HYALURONIC ACID FOR HIP OSTEOARTHRITIS. Osteoarthritis and Cartilage. 16. S113–S113. 2 indexed citations

Dougados, Maxime, Laure Gossec, Minh Nguyen, et al.. (2007). 411 REQUIREMENT FOR TOTAL ARTICULAR REPLACEMENT AFTER DIACEREIN TREATMENT IN HIP OSTEOARTHRITIS: A 5 YEARS FOLLOW-UP OF THE 3 YEARS PLACEBO-CONTROLLED ECHODIAH TRIAL. Osteoarthritis and Cartilage. 15. C223–C223.

Gossec, Laure, Anne Le Hénanff, Maxime Bréban, et al.. (2006). Continuation of treatment with infliximab in ankylosing spondylitis: 2-yr open follow-up. Lara D. Veeken. 45(7). 859–862. 18 indexed citations

Maillefert, J.F., Minh Nguyen, Alice Guéguen, et al.. (2002). Relevant change in radiological progression in patients with hip osteoarthritis. II. Determination using an expert opinion approach. Lara D. Veeken. 41(2). 148–152. 23 indexed citations

Vignon, E, Patrick Garnero, Pierre Delmas, et al.. (2001). Recommendations for the registration of drugs used in the treatment of osteoarthritis: an update on biochemical markers. Osteoarthritis and Cartilage. 9(4). 289–293. 31 indexed citations

Vignon, E, et al.. (1999). Effect of tiludronate in fibrous dysplasia of bone. A case-report.. PubMed. 66(12). 748–50. 1 indexed citations

Dougados, Maxime, Alice Guéguen, Minh Nguyen, et al.. (1999). Requirement for total hip arthroplasty: an outcome measure of hip osteoarthritis?. PubMed. 26(4). 855–61. 68 indexed citations

10.

Portoukalian, Jacques, et al.. (1995). Gangliosides from normal and osteoarthritic joints.. PubMed. 43. 133–5. 9 indexed citations

11.

Graverand, M.-P. Hellio Le, et al.. (1995). ASSESSMENT OF URINARY HYDROXYPYRIDINIUM CROSS-LINKS MEASUREMENT IN OSTEOARTHRITIS. Lara D. Veeken. 35(11). 1091–1095. 20 indexed citations

12.

Conrozier, T, Pierre Mathieu, Pierre Broquet, et al.. (1994). [Serum phospholipase A2 activity in osteoarthritis].. PubMed. 61(5). 311–7. 1 indexed citations

13.

Hartmann, D, Pierre Mathieu, T Conrozier, et al.. (1993). [Serum hyaluronic acid in osteoarthritis].. PubMed. 60(3). 194–202. 3 indexed citations

14.

Vignon, E, et al.. (1990). [In vitro evaluation of a chondro-protector].. PubMed. 57(9 ( Pt 2)). 15S–18S. 2 indexed citations

15.

Hartmann, D, et al.. (1986). Caractérisation et dosage des anticorps anti-collagènes par technique radio-immunologique en phase solide.. Annales de biologie clinique. 44(3). 3 indexed citations

16.

Vignon, E, et al.. (1986). [Quantitative study of experimental osteoarthritic lesions in the rabbit. Value for the study of anti-osteoarthritis drugs].. PubMed. 53(11). 649–52. 4 indexed citations

17.

Vignon, E. (1978). [Physiopathology of arthrosis].. PubMed. 28(15). 1179–86. 1 indexed citations

18.

Vignon, E, et al.. (1976). The Cell Density of Human Femoral Head Cartilage. Clinical Orthopaedics and Related Research. 121(121). 303–308. 97 indexed citations

19.

Vignon, E, M C Chapuy, M Arlot, et al.. (1975). [Study of the concentration of glycosaminoglycans in cartilage from normal and osteoarthritic femoral head].. PubMed. 23(4). 283–9. 2 indexed citations

20.

Richard, M, E Vignon, & Pierre Louisot. (1972). Particulate glycosyl-transferases in cartilage and human arthrosis.. PubMed. 17(5). 503–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact